Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17050875 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma
Conditions: Colorectal Neoplasms;   Metastases, Neoplasm
Intervention: Biological: Erbitux (Cetuximab)

Study has passed its completion date and status has not been verified in more than two years.